Study of Low White Blood Cell Counts and Blood Types in Newborns
Part of Blood & lymphatic clinical trials.
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby born at Kaplan Medical Center between September 1, 2024 and December 31, 2025.
- Parent gives permission for the study.
- Umbilical cord blood sample is available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at premature babies and babies with very low birth weight to better understand a serious bowel condition called necrotizing enterocolitis. It aims to find ways to identify or manage this condition in these high-risk infants.
This study tests a way to track your blood counts at home using a finger-stick device and a smartphone app. It may help people with severe chronic neutropenia, a condition with very low white blood cells, manage their care more easily.
This study looks at the causes of pancytopenia, a condition where all three types of blood cells (red, white, and platelets) are lower than normal. By doing blood tests and a bone marrow biopsy, doctors hope to better understand what is causing it and improve care.
This study tests whether red blood cells made from donated cord blood are safe and effective for very premature babies who need a transfusion. It may offer an alternative to standard donor blood for these fragile infants.
This study looks at why some newborns develop anemia (low red blood cells) and how it affects their health in the NICU. It aims to find better ways to care for babies with this condition.
This study tests whether umbilical cord blood cells can help people whose blood counts stay dangerously low after immune-based cancer treatments like CAR-T or bispecific antibodies. The treatment aims to boost your blood cell recovery and reduce the need for transfusions.
Hear when a new Neutropenia (Low White Blood Cell Count) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.